Home › Burkitt Lymphoma › Wisconsin › Milwaukee

Pag-aaral pangklinika para sa Burkitt Lymphoma sa Milwaukee, WI

16 pag-aaral para sa Burkitt Lymphoma ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Milwaukee (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Nagre-recruitPhase 2

Children's Hospital of Wisconsin, Milwaukee

366 Days – 46 Years · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06124157

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Nagre-recruitPhase 3

Medical College of Wisconsin, Milwaukee

Edad 18 hanggang 39 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT03150693

Blinatumomab Consolidation in Real World

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Medical College of Wisconsin, Milwaukee

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07117136

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Nagre-recruitObservasyonal na pag-aaral

Children's Hospital of Wisconsin, Milwaukee

Edad 0 hanggang 38 · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06131801

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

Nagre-recruitPhase 2

Medical College of Wisconsin, Milwaukee
Drexel Town Square Health Center, Oak Creek · 11 mi ang layo
Froedtert and MCW Moorland Reserve Health Center, New Berlin · 11 mi ang layo
at 1 pa

Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT03739814

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Nagre-recruitPhase 2

Children's Hospital of Wisconsin, Milwaukee

365 Days · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06317662

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

Nagre-recruitPhase 3

Medical College of Wisconsin, Milwaukee

Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07648264

Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

Nagre-recruitPhase 1

Medical College of Wisconsin, Milwaukee

Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT03666000

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Nagre-recruitPhase 2

Children's Hospital of Wisconsin, Milwaukee

Edad 1 hanggang 30 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Nagre-recruitPhase 3

Children's Hospital of Wisconsin, Milwaukee

365 Days – 25 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT03959085

AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

Nagre-recruitPhase 1/2

Research Site, Milwaukee

Edad 12 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT06137118

LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies

Nagre-recruitPhase 1

Froedtert & the Medical College of Wisconsin, Milwaukee

Edad 18 hanggang 81 · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT05990465

MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing

Nagre-recruit

Children's Wisconsin, Milwaukee

Edad 0 hanggang 25 · Lahat ng kasarian · Na-update May 13, 2026 · NCT05794880

Study of SGR-1505 in Mature B-Cell Neoplasms

Nagre-recruitPhase 1

Medical College of Wisconsin, Milwaukee

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 13, 2026 · NCT05544019

Long-term Follow-up Study of Patients Receiving CAR-T Cells

Nagre-recruitObservasyonal na pag-aaral

Froedtert Hospital & Medical College of Wisconsin, Milwaukee

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Nob 10, 2025 · NCT03375619

Blinatumomab After TCR Alpha Beta/CD19 Depleted HCT

Nagre-recruitPhase 2

Children's Hospital of Wisconsin, Milwaukee

Hanggang edad 25 · Lahat ng kasarian · Na-update Set 17, 2021 · NCT04746209

Pag-aaral para sa Burkitt Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Milwaukee

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.